Verona Pharma Plc Stock Market Value
| VRNA Stock | USD 64.17 1.78 2.85% |
| Symbol | Verona |
Verona Pharma PLC Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Verona Pharma. If investors know Verona will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Verona Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Verona Pharma PLC is measured differently than its book value, which is the value of Verona that is recorded on the company's balance sheet. Investors also form their own opinion of Verona Pharma's value that differs from its market value or its book value, called intrinsic value, which is Verona Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Verona Pharma's market value can be influenced by many factors that don't directly affect Verona Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Verona Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Verona Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Verona Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Verona Pharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Verona Pharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Verona Pharma.
| 01/27/2025 |
| 02/26/2025 |
If you would invest 0.00 in Verona Pharma on January 27, 2025 and sell it all today you would earn a total of 0.00 from holding Verona Pharma PLC or generate 0.0% return on investment in Verona Pharma over 30 days. Verona Pharma is related to or competes with Ventyx Biosciences, Ideaya Biosciences, Protagonist Therapeutics, Syndax Pharmaceuticals, Day One, X4 Pharmaceuticals, and Inozyme Pharma. Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies... More
Verona Pharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Verona Pharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Verona Pharma PLC upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.65 | |||
| Information Ratio | 0.2765 | |||
| Maximum Drawdown | 17.34 | |||
| Value At Risk | (3.82) | |||
| Potential Upside | 6.62 |
Verona Pharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Verona Pharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Verona Pharma's standard deviation. In reality, there are many statistical measures that can use Verona Pharma historical prices to predict the future Verona Pharma's volatility.| Risk Adjusted Performance | 0.2143 | |||
| Jensen Alpha | 0.9256 | |||
| Total Risk Alpha | 0.9035 | |||
| Sortino Ratio | 0.3473 | |||
| Treynor Ratio | 13.13 |
Verona Pharma PLC Backtested Returns
Verona Pharma appears to be very steady, given 3 months investment horizon. Verona Pharma PLC owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.25, which indicates the firm had a 0.25 % return per unit of risk over the last 3 months. By inspecting Verona Pharma's technical indicators, you can evaluate if the expected return of 0.84% is justified by implied risk. Please review Verona Pharma's Semi Deviation of 2.14, risk adjusted performance of 0.2143, and Coefficient Of Variation of 355.83 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Verona Pharma holds a performance score of 19. The entity has a beta of 0.0705, which indicates not very significant fluctuations relative to the market. As returns on the market increase, Verona Pharma's returns are expected to increase less than the market. However, during the bear market, the loss of holding Verona Pharma is expected to be smaller as well. Please check Verona Pharma's skewness, and the relationship between the potential upside and rate of daily change , to make a quick decision on whether Verona Pharma's existing price patterns will revert.
Auto-correlation | 0.75 |
Good predictability
Verona Pharma PLC has good predictability. Overlapping area represents the amount of predictability between Verona Pharma time series from 27th of January 2025 to 11th of February 2025 and 11th of February 2025 to 26th of February 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Verona Pharma PLC price movement. The serial correlation of 0.75 indicates that around 75.0% of current Verona Pharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.75 | |
| Spearman Rank Test | 0.57 | |
| Residual Average | 0.0 | |
| Price Variance | 4.43 |
Verona Pharma PLC lagged returns against current returns
Autocorrelation, which is Verona Pharma stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Verona Pharma's stock expected returns. We can calculate the autocorrelation of Verona Pharma returns to help us make a trade decision. For example, suppose you find that Verona Pharma has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Verona Pharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Verona Pharma stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Verona Pharma stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Verona Pharma stock over time.
Current vs Lagged Prices |
| Timeline |
Verona Pharma Lagged Returns
When evaluating Verona Pharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Verona Pharma stock have on its future price. Verona Pharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Verona Pharma autocorrelation shows the relationship between Verona Pharma stock current value and its past values and can show if there is a momentum factor associated with investing in Verona Pharma PLC.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Verona Pharma PLC offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Verona Pharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Verona Pharma Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Verona Pharma Plc Stock:Check out Verona Pharma Correlation, Verona Pharma Volatility and Verona Pharma Alpha and Beta module to complement your research on Verona Pharma. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Verona Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.